by Katrina Rogers | Feb 18, 2020 | COVID
Chapter 1 – What is a Coronavirus? A coronavirus is a virus that typically causes respiratory symptoms in affected persons. It’s name comes from the tiny projections extending from the membrane that contains the viral DNA, which have the appearance of a crown,...
by Katrina Rogers | Feb 13, 2020 | Medicine
As we approach Rare Disease Day this year (February 29th), I’d like to share this PharmaVOICE article on the impact of rare diseases and the efforts underway to address these challenges. As the article notes, while these diseases may be rare because they individually...
by Katrina Rogers | Feb 11, 2020 | Medical Products
There’s a lot of investment capital floating around out there, and the Pharmaceuticals and Life Sciences (PLS) sector could benefit this year. According to a report by international accounting firm PwC, there’s considerable money and investment interest in the space,...
by Katrina Rogers | Feb 6, 2020 | Medical Products, Medicine, Product Development
Alnylam Pharmaceuticals recently announced a new Value Based Agreement (VBA) framework for their newly approved RNAi medicine to treat acute hepatic porphyria, a group of rare genetic diseases due to one or more deficiencies in the heme biosynthesis pathway in the...
by Katrina Rogers | Feb 4, 2020 | Uncategorized
Regular readers will recall my post earlier this year on the shutdown of a Sterigenics plant in Illinois using ethylene oxide to sterilize medical devices due to repeat environmental emissions of the sterilant, which is known to cause cancer. The shutdown continues...
Recent Comments